PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $845,000 | -68.7% | 108,000 | -50.9% | 0.06% | -68.0% |
| Q4 2016 | $2,697,000 | -21.4% | 220,000 | 0.0% | 0.18% | -16.3% |
| Q3 2016 | $3,430,000 | +41.4% | 220,000 | +10.0% | 0.21% | +41.2% |
| Q2 2016 | $2,426,000 | +25.8% | 200,000 | 0.0% | 0.15% | +37.0% |
| Q1 2016 | $1,928,000 | – | 200,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 722,890 | $911,000 | 0.53% |
| GREAT POINT PARTNERS LLC | 3,500,000 | $4,410,000 | 0.44% |
| NEA Management Company, LLC | 5,556,778 | $7,002,000 | 0.36% |
| SECTORAL ASSET MANAGEMENT INC | 2,050,328 | $2,583,000 | 0.31% |
| HARBOURVEST PARTNERS LLC | 440,627 | $555,000 | 0.20% |
| VHCP Management II, LLC | 427,110 | $538,000 | 0.16% |
| Endurant Capital Management LP | 130,600 | $165,000 | 0.06% |
| ALGERT GLOBAL LLC | 64,300 | $81,000 | 0.05% |
| Bain Capital Public Equity Management, LLC | 231,418 | $292,000 | 0.03% |
| Kazazian Asset Management, LLC | 14,436 | $18,000 | 0.02% |